- 大会
- 英卡思美洲年会 - 2025年 4月
- 英卡思亚洲年会 - 2025年 6月
- 英卡思中国大会 - 2025年 7月
- 英卡思巴黎国际年会 - 2026年 1月
- 大师精品课
- 英卡思印度大会 - 2025年 11月
- 大会
- 英卡思美洲年会 - 2025年 4月
- 英卡思亚洲年会 - 2025年 6月
- 英卡思中国大会 - 2025年 7月
- 英卡思巴黎国际年会 - 2026年 1月
- 大师精品课
- 英卡思印度大会 - 2025年 11月

英卡思学院

注册新账号

介绍
大会日程
讲者
赞助企业名单
大会地图
认证

回到上页

2025 英卡思巴黎国际年会
大会日程

针对您所在时区的直播课程/会议的时间

时区参照: (UTC+02:00) Europe, Paris

时区

时区:改换时区

If you are logged in, change your default time zone in your account

Non-surgical body contouring (in collaboration with PSAD)

Partner of the session

PSAD

Polish Society for Aesthetic Dermatology

波兰

会议室： Room 401 - Level 4
日期： 2025年 2月 1日星期六从 14:00 至 15:30
组织形式： 聚焦课程 > 涵盖大会的一个主要议题

主席

Jakub KRYSTIAN 医师

美容整型外科医师

波兰

Ines VERNER 医师

皮肤科医师

以色列

本场演讲内容

小时	讲者	演讲标题	讲稿摘要	数字
14:00	Oge ONWUDIWE 医师	Combined use of biostimulators and energy based devices in the treatment of body laxity		142778
14:12	Luiz Eduardo TOLEDO AVELAR 医师	Non-surgical treatment for abdominal laxity		144649
14:24	Shadi KOUROSH 医师	Energy based devices in body contouring		142850
14:36	Stefania GUIDA 医师	Post-liposuction skin irregularities: Classification and treatment with diluted/hyperdiluted calcium hydroxylapatite		142780
14:48	Jakub KRYSTIAN 医师	Modeling of buttocks and treatment of proctological diseases using aesthetic medicine procedures	查看	142779
15:00	Michael H GOLD 医师	A novel non-surgical fat reduction treatment: A phase 2b study investigating CBL-514 injection’s efficacy in reducing abdomen subcutaneous fat	查看	145854
15:12		Discussion and Q&A		142781

进入前一场会议

进入下一场会议

推荐会议

非手术塑体（非手术）

注射剂：非透明质酸类（聚左旋乳酸、羟基磷灰石钙等）

紧肤

臀部（非手术）

脂肪团

Oge ONWUDIWE 医师

皮肤科医师

美国

其他作者 :

Combined use of biostimulators and energy based devices in the treatment of body laxity

Objectives: Attendees will learn the effectiveness of Combined use of Biostimulators and Energy based devices in the treatment of body laxity

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Luiz Eduardo TOLEDO AVELAR 医师

整形外科医师

巴西

其他作者 :

Non-surgical treatment for abdominal laxity

Objectives: Abdominal laxity is a very common situation after rapid weight loss, postpartum, and the aging process. Knowing that we have tools to treat it and also how to treat it makes a difference. This presentation will share where to address the product, the number of vials, the maintenance, and when to avoid the treatment.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Shadi KOUROSH 医师

皮肤科医师

美国

其他作者 :

Energy based devices in body contouring

Objectives: * Provide an overview and update on advances in energy based devices for body contouring, skin tightening and cellulite
* Compare and contrast the mechanism of action behind the different technologies and their relative strengths and weaknesses
* Discuss and highlight the key role of aesthetic doctors and our knowledge of energy based / non-surgical body contouring in the weight loss revolution of semiglutide injectable drugs, and how these modalities can be utilized to treat the negative effects of “Ozempic body”

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Stefania GUIDA 医师

皮肤科医师

意大利

其他作者 :

Post-liposuction skin irregularities: Classification and treatment with diluted/hyperdiluted calcium hydroxylapatite

Objectives: Recently, the use of fillers with biostimulatory activities, such as CaHA, aiming at the increase of neocollagenesis, neoangiogenesis and increased elastin, has been proposed as an off-label treatment of skin laxity of the body.
Recently, we published a definition and classification for post-liposuction skin irregularities (PLSI). Previously unreported data related to treatment of PLSI with CaHA, leading to good-to-excellent results, will be presented.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Jakub KRYSTIAN 医师

美容整型外科医师

波兰

其他作者 :

Modeling of buttocks and treatment of proctological diseases using aesthetic medicine procedures

Objectives: Contrary to popular belief, aesthetic medicine is not only about taking care of superficiality, improving beauty defects, raising self-esteem and expressing financial wealth. It gives a lot of tools that properly applied will give what „standard” medicine can not – chance for normal functioning and recovery .

Introduction: Aesthetic proctology uses the existing medical activities in the field of aesthetic medicine, which significantly accelerate the healing process, they reduce pain and allow you to perform treatments in an outpatient mode, which significantly affects the maintenance of an atmosphere of intimacy during treatments. In addition, it gives new treatment options and complements standard surgical procedures.

Materials / method: Presentation of clinical cases of my patients who have used aesthetic medicine procedures in the treatment of proctological diseases

Results: Visible in the presented clinical cases, in which a significant acceleration of the healing process was obtained, a reduction in the time of return to normal functioning and full health

Conclusion: The use of aesthetic medicine procedures in proctology significantly accelerates the healing and tissue repair processes. It gives the possibility of a faster recovery and gives hope to people in whom standard surgical treatment is insufficient

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Michael H GOLD 医师

皮肤科医师

美国

其他作者 :

A novel non-surgical fat reduction treatment: A phase 2b study investigating CBL-514 injection’s efficacy in reducing abdomen subcutaneous fat

Objectives: To evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat compared to placebo by using Abdominal Fat Rating Scale (AFRS) and MRI to assess the efficacy.

Introduction: CBL-514 is a lipolysis injection that can induce adipocyte apoptosis to reduce subcutaneous fat. The latest Phase 2b study showed that compared with the placebo group, the LS mean difference of the subcutaneous fat volume change eight weeks after CBL-514 treatments were -28.1 % (p< 0.001) and -276.8mL (p< 0.0001). The efficacy of CBL-514 for fat reduction is comparable to or exceeds that of liposuction, with a favorable safety profile.

Materials / method: A total of 107 participants with moderate to severe abdominal subcutaneous fat accumulation as assessed by the investigator via live evaluation using the CR-AFRS were enrolled and randomized in a 1:1 ratio to receive up to 4 treatments of allocated CBL-514 or placebo administered subcutaneously to the abdomen, once every 3 weeks, along with 3 follow-up visits at 4, 8, and 12 weeks post the last treatment

Results: All efficacy endpoints achieved. The results demonstrated that 81.8% of CBL-514-treated participants compared with placebo (16.7% and 18.5%)achieved at least 1-grade improvement. 58.8% of the participants only required one CBL-514 treatment to achieve at least 1-grade CR-AFRS improvement. Compared to the placebo group, CBL-514 reduced an average of over 31 % of abdominal subcutaneous fat thickness in PP population. Overall, the safety and tolerability profiles of CBL-514 were favorable and consistent with previous CBL-514 clinical studies.

Conclusion: CBL-514, the first-in-class new injectable drug for large-area fat reduction, appears to provide significant benefits for subcutaneous fat accumulation, suggesting it may be a promising, novel, better non-surgical fat reduction option warranting further Phase 3 investigation in a larger population.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
是
请注明名称（个人，公司，学会等等）: Caliway Biopharmaceuticals

您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: Caliway Biopharmaceuticals/ Honorarium for Consulting

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： Caliway Biopharmaceuticals

Discussion and Q&A

您有问题要问？

在我们的常见问题解答中快速找到答案

大会

英卡思美洲年会
英卡思亚洲年会
英卡思中国大会
英卡思巴黎国际年会

关于我们

公司
隐私政策
法律信息

学院

主页
课程
Webinars
探索
博客

支援

教育援助

保持联系

联系我们

登录名/电邮地址

密码

保持登录状态

密码遗失 ? 还没有账号？现在注册

保持登录状态

academy.Do_not_have_an_account_yet 现在注册

2025 英卡思巴黎国际年会 大会日程

Non-surgical body contouring (in collaboration with PSAD)

主席

本场演讲内容

推荐会议

2025 英卡思巴黎国际年会
大会日程

本场演讲内容